Associated Banc Corp Gilead Sciences, Inc. Transaction History

Associated Banc Corp

$3.2 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $45,940 - $52,097	-627 Reduced 19.8%	2,540 $205,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $94,936 - $108,288	-1,249 Reduced 28.28%	3,167 $244,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $79,242 - $90,282	-1,025 Reduced 18.84%	4,416 $366,000
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $10,656 - $15,299	-171 Reduced 3.05%	5,441 $467,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $1,443 - $1,625	25 Added 0.45%	5,612 $347,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $9,614 - $12,048	-166 Reduced 2.89%	5,587 $332,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $89,210 - $101,255	-1,375 Reduced 19.29%	5,753 $418,000
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $58,551 - $63,170	-865 Reduced 10.82%	7,128 $497,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $718,289 - $784,833	-11,317 Reduced 58.61%	7,993 $550,000
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $350,280 - $399,669	5,838 Added 43.33%	19,310 $1.44 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $154,654 - $176,221	-2,730 Reduced 16.85%	13,472 $785,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $172,141 - $216,437	-2,772 Reduced 14.61%	16,202 $1.02 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $197,922 - $229,824	-2,736 Reduced 12.6%	18,974 $1.46 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $252,273 - $323,126	4,028 Added 22.78%	21,710 $1.62 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $62,297 - $68,525	-1,011 Reduced 5.41%	17,682 $1.15 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $89,139 - $98,394	-1,426 Reduced 7.09%	18,693 $1.19 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $1,051 - $1,179	-17 Reduced 0.08%	20,119 $1.36 Million
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $33,828 - $37,897	-541 Reduced 2.62%	20,136 $1.31 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $283,145 - $369,483	-4,677 Reduced 18.45%	20,677 $1.29 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $50,038 - $55,401	-702 Reduced 2.69%	25,354 $1.96 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $1.69 Million - $1.97 Million	26,056 New	26,056 $1.85 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Account